VAERS Explorer
Back to explore

Report #2837635

Received Apr 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNK——

Symptoms (2)

Injection site erythemaInjection site warmth

Symptom narrative

experienced diffuse redness around and below the injection site; the site was red and felt hot for about 3 days; This spontaneous report was received from a consumer referring to a female patient, age was not provided. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On an unknown date, the patient was vaccinated with pneumococcal 21-valent conjugate (CAPVAXIVE) injection, administered intramuscularly as a dose of 0.5 ml for prophylaxis (anatomical location, lot number and expiration date were not reported). On an unknown date, reported as 1 day after vaccination, the patient experienced diffuse redness around and below the injection site (Redness), the site was red and felt hot (Vaccination site warmth) for about 3 days and then subsided without intervention or medication. At the time of the reporting, the outcome of the event was recovered. The causal relationship between the events and the suspect therapy was not provided.; Reporter's Comments: